Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Reservoir SMACdown could fight latent HIV

Oct. 23, 2018

Merck Sharp & Dohme enrolling patients in phase I study of MK-8583 for HIV-1

Oct. 22, 2018

MacroGenics studies MGD-014 in patients with HIV infection on suppressive ART

Oct. 22, 2018

Aelix and Gilead collaborate to study HTI T-cell vaccine with vesatolimod in HIV

Oct. 19, 2018

ST Pharm discovers new HIV integrase inhibitors

Oct. 19, 2018

GS-6207 shows long-acting nonclinical pharmacokinetic profile

Oct. 11, 2018

Vedolizumab may help eliminate HIV infection by attenuating lymphoid aggregates

Oct. 9, 2018

Two-fisted punch prevents HIV rebound

Oct. 8, 2018

NK problems facilitate bnAbs in HIV

Oct. 2, 2018

BIT225-009 phase II study demonstrates significant immunological benefits in HIV-infected patients

Oct. 1, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...